Seascape Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,897
Closed -$315K 86
2022
Q1
$315K Sell
14,897
-4,573
-23% -$98.5K 0.16% 75
2021
Q4
$460K Sell
19,470
-1,814
-9% -$38.9K 0.22% 75
2021
Q3
$427K Sell
21,284
-97,031
-82% -$1.99M 0.22% 78
2021
Q2
$2.38M Buy
118,315
+4,489
+4% +$96K 1.24% 34
2021
Q1
$2.42M Buy
113,826
+3,699
+3% +$79.5K 1.35% 28
2020
Q4
$2.4M Buy
110,127
+5,732
+5% +$112K 1.4% 20
2020
Q3
$1.84M Sell
104,395
-1,905
-2% -$35.5K 1.17% 32
2020
Q2
$2M Sell
106,300
-5,433
-5% -$96.2K 1.43% 21
2020
Q1
$1.93M Sell
111,733
-4,157
-4% -$86.9K 1.75% 13
2019
Q4
$2.45M Buy
+115,890
New +$2.35M 1.75% 17

Other funds holding MPT

Seascape Capital Management's MPT Position: Q2 2022 in Review

Seascape Capital Management sold out of Medical Properties Trust (MPT) in Q2 2022, closing a stake of 14,897 shares — an estimated $315K sold.

Seascape Capital Management first reported a position in MPT in Q4 2019 and held it in 10 quarters. The position peaked at $2.45M in Q4 2019. 605 funds tracked by Wall St. Rank hold MPT as of Q2 2022.

  • Seascape Capital Management reported no remaining Medical Properties Trust position as of Q2 2022 after selling out during the quarter.
  • Seascape Capital Management sold 14,897 Medical Properties Trust shares in Q2 2022, an estimated $315K.
  • Seascape Capital Management first reported a position in Medical Properties Trust in Q4 2019 and held it in 10 quarters.
  • Seascape Capital Management's Medical Properties Trust position peaked at $2.45M in Q4 2019.
  • 605 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2022.

Based on Seascape Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.